论文部分内容阅读
目的 :分析莫沙必利、黛力新治疗临床消化不良的治疗效果。方法 :采用入院的210例随机挑选的患者,平均分为三个组别,每组70人。研究组对患者口服莫沙必利和黛力新综合治疗,对照一组对患者口服莫沙必利,对照二组对患者口服奥美拉唑治疗。分别观察三组患者的临床治疗1效果,记录并分析治疗反应。结果 :通过研究组和对照组的治疗效果分析,明显研究组的治疗效果优于对照一组合对照二组的治疗。在统计学上不存在差异性问题。三组患者均未出现不良症状。结论:根据治疗功能状态进行不良分析,研究莫沙必利联合黛力新的治疗效果,对莫沙必利的功能性问题具有良好的功能性作用。
Objective: To analyze the therapeutic effect of Mosapride and Deanxit in the treatment of clinical dyspepsia. METHODS: A total of 210 randomly selected patients admitted to the hospital were divided into three groups of 70 in each. In the study group, mosapride and Deanxit were given to patients orally. One group was given mosapride orally and the other two groups were given omeprazole orally. Three groups of patients were observed for clinical treatment 1 effect, record and analyze the treatment response. Results: Through the analysis of the treatment effect of the study group and the control group, the treatment effect of the study group was obviously better than that of the control group and the control group. There are no statistically significant differences. Three groups of patients did not appear adverse symptoms. CONCLUSIONS: The adverse effects of treatment with functional status of Mosapride combined with Deanxit have a good functional effect on the functional problems of mosapride.